Merck KGaA (XBUL:MRK) COGS-to-Revenue : 0.40 (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Merck KGaA COGS-to-Revenue?

Merck KGaA's Cost of Goods Sold for the three months ended in Sep. 2024 was лв4,392 Mil. Its Revenue for the three months ended in Sep. 2024 was лв10,900 Mil.

Merck KGaA's COGS to Revenue for the three months ended in Sep. 2024 was 0.40.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Merck KGaA's Gross Margin % for the three months ended in Sep. 2024 was 59.70%.

Merck KGaA COGS-to-Revenue Historical Data

The historical data trend for Merck KGaA's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA COGS-to-Revenue Chart

Merck KGaA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.37

0.39

0.37

0.38

0.41

Merck KGaA Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
COGS-to-Revenue	Get a 7-Day Free Trial															0.42	0.45	0.41	0.40	0.40

Merck KGaA COGS-to-Revenue Calculation

Merck KGaA's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	17489.793	/	42693.398
	=	0.41

Merck KGaA's COGS to Revenue for the quarter that ended in Sep. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	4392.139	/	10899.626
	=	0.40

Merck KGaA (XBUL:MRK) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Merck KGaA's Gross Margin % for the three months ended in Sep. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	4392.139 / 10899.626
	=	59.70 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Merck KGaA COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Merck KGaA's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Merck KGaA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (XBUL:MRK) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

MKKGY:USA MKGAF:USA MRK1:Mexico 1MRK:Italy MRKd:UK 0O14:UK MRK:Germany

Address

Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293

Website

https://www.emdgroup.com

Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (44% of 2023 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (38%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (17%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.